Acetaminophen Cancer Risk To Be Evaluated Under California Prop 65 Law

California health officials may add acetaminophen, the active ingredient in Tylenol and other widely used pain medications, to a statewide list of chemicals that may cause cancer.

According to an Associated Press report published this week, the California Office of Environmental health Hazard Assessment (OEHHA) is reviewing the cancer side effects of acetaminophen, to determine whether it should be included on the state’s Prop 65 list.

If acetaminophen is added to the list, California law would require that any products sold in the state that contain the ingredient include a cancer risk label warning.

Tylenol Autism Lawsuit

Does your child have Austism from Tylenol Exposure?

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Learn More See If You Qualify For Compensation

The OEHHA first announced that it is looking at acetaminophen as a potential entry to the list in a federal register notice on March 15, 2019.

On December 5, the state’s Carcinogen Identification Committee (CIC), a panel of governor-appointed scientists which reviews potential Prop 65 candidates, held a public meeting on potential inclusion of acetaminophen and released its review of the evidence.

The CIC evidence review (PDF) indicates it looked at 133 acetaminophen studies, some of which have linked the popular painkiller to cancer, while others have not. They found that metabolizing acetaminophen can cause electrophilic and genotoxic metabolites to form, and that it tested positive for a number of other genotoxicity endpoints.

The comment period on the committee’s findings ends on January 27. However, both the FDA and the World Health Organization’s International Agency for Research on Cancer (IARC) have declined to list acetaminophen as a potential cancer-causing agent, following their own reviews of the evidence over the years.

Industry associations also say they plan to fight the drug’s inclusion on the list, which often has far-reaching effects beyond California, the state with the nation’s largest economy.

Acetaminophen is the active ingredient in Tylenol and other cold and pain medications. While most consumers assume that the drug is safe, acetaminophen is the leading cause for liver injury in the United States, causing an estimated 50,000 emergency room visits each year, including 25,000 hospitalizations and over 450 deaths annually. In addition, use of the medication has been linked to a risk of dangerous skin reactions, like Stephens-Johnson Syndrome.

In recent years, efforts have been ramped up to bring the risk of acetaminophen overdoses to the public’s attention and to reduce the amount of liver injury cases linked to the popular analgesic, which is also found in Tylenol, other pain killers and a number of cold medications.

0 Comments

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court
Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (Posted 2 days ago)

A federal judge has issued pretrial schedules for the first two BioZorb lawsuits to go before juries starting in September, calling for the parties to outline all the issues of contention, witnesses and facts to be presented during the bellwether early test cases.

Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week
Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (Posted 4 days ago)

A federal magistrate judge has accepted new deadlines for expert discovery in Covidien hernia mesh lawsuits, which will also result in the selection of a mediator by February 24, to shepherd the parties through settlement negotiations.